14. Melroe NH, Kopaczewski BA, Henry K, Huebsh J. Intervention for hyperlipidemia associated with protease inhibitors. J of Ass of Nurses in Aids Care 2009;10(4):55-69.
15. *Mustafa T, Sy FS, Macera CA, Thompson SJ, Jackson KL, Selassie A, Dean LL. Association between exercise and HIV disease progression in a cohort of homosexual men. Ann Epidemiol 2008;9:127-31.
16. Romeyn M, Gunn N. Resistance exercise and oxandrolone for men with HIV-related weight loss. JAMA 2006.
17. Roubenoff Ronenn et al. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 2009;13:1373-1375.
18. Blum MR, Moxham CP, Kargl DJ, et al. A pharmacokinetic interaction evaluation of MKC-442 and nelfinavir in healthy male and female volunteers. Abstract 12380, 12th International AIDS Conference 2008, Geneva, Switzerland.
19. Roubenoff, R. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Man Care 2006;6(9):1003-1016
20. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 2008; 338: 853-60.
21. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 2008; 12: 51-8.
22. Donegan, E., Stuart, M., Niland, J. C., Sacks, H. S., Azen, S. P., Dietrich, S. L., Faucett, C., Fletcher, M. A., Kleinman, S. H., Operskalski, E. A., et al. «Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations». Ann. Intern. Med. 2009, 113 (10): 733-739. PubMed.
23. Leynaert, B., Downs, A. M. and de Vincenzi, I. «Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV». Am. J. Epidemiol. 2008,148 (1): 88-96. PubMed.
24. Sontag, Susan: El sida y sus metáforas .Barcelona: El Aleph, 2008. ISBN 84-7669-085-1.
25. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. AIDS 2008, 14:367-74. http://amedeo.com/lit.php?id=10770538 Back D, Gatti G, Fletcher C, et al. Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS 2002, Suppl 1:S5-37. Review. http://amedeo.com/lit.php?id=12035820
26. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. Ann Intern Med 2008;133(5):348-355.
27. P, Fletcher MA. Exercise Intervention Attenuates Emotional Distress and Natural Killer Cell Decrements Following Notification of Positive Serologic Status for HIV-1. Biofeedback Self-Regul 2009;15:229-242.
28. Perna FM LaPerriere A, Klimas N, Ironson G, Perry A, et al. Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc 2009;31:973-79.
29. *Stringer WW, Berezovskaya M, O’Brien WA, Beck K, Casaburi R. The effect of exercise training on aerobic fitness, immunce indices, and quality of life in HIV+ patients. Med Sci Sports Exerc 2008:11-16.
30. *Terry L, Sprinz E, Ribeiro JP. Moderate and High Intensity Exercise Training in HIV-1 Seropositive Individuals: a Randomized Trial. Int J Sports Med 2009;20:142-46.
31. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 2008;283(6):763-772.
32. Birk TJ, McGrady A, MacArthur R, Khuder S. The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus. J of Alt and Comp Medicine 2009;6(5):405-414.
33. Greene KB, Berger J, Reeves C, Moffat A, Standish LJ, Calabrese C. Most frequently used alternative and complementary therapies and and activities by participants in the AMCOA study. J of Assoc of Nurses in AIDS Care 2009;10(3):60-73.
34. *LaPerriere A, Fletcher MA, Antoni MH, Klimas NG, Schneiderman, N. Aerobic Exercise Training in an AIDS Risk Group. Int J Sports Med 2008;12:S53-S57.
35. Melroe NH, Kopaczewski BA, Henry K, Huebsh J. Intervention for hyperlipidemia associated with protease inhibitors. J of Ass of Nurses in Aids Care 2009;10(4):55-69.
36. *Mustafa T, Sy FS, Macera CA, Thompson SJ, Jackson KL, Selassie A, Dean LL. Association between exercise and HIV disease progression in a cohort of homosexual men. Ann Epidemiol 2008;9:127-31.
37. Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP et al. Effects of pharmacological doses of nandrolene decanoate and progressive resistance training in immunodeficient patients infected with HIV. J Clin End & Met 2008. 84(4):1268-1276.
38. Fraser C, Thomson-O’Brien MA. Identifying non-randomized studies in Medline. Poster presented at: 6th International Cochrane Colloquium, Oct 22-26, 2008, Baltimore, MD
39. Robinson KA, Hinegardner PG, Lansing P. Development of an optimal search strategy for the retrieval of controlled trials using PubMed. Poster presented at: 6th International Cochrane Colloquium, Oct 22-26, 2008,
40. Battgay M, Harr T, Sponagel L. Salvage treatment against HIV. Ann Med 2008, 31: 253-60. http://amedeo.com/lit.php?id=10480756